valerates has been researched along with angiotensin ii in 4 studies
| Studies (valerates) | Trials (valerates) | Recent Studies (post-2010) (valerates) | Studies (angiotensin ii) | Trials (angiotensin ii) | Recent Studies (post-2010) (angiotensin ii) |
|---|---|---|---|---|---|
| 2,251 | 294 | 457 | 38,152 | 1,089 | 7,413 |
| Protein | Taxonomy | valerates (IC50) | angiotensin ii (IC50) |
|---|---|---|---|
| Atrial natriuretic peptide receptor 3 | Homo sapiens (human) | 0.002 | |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.002 | |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0018 | |
| Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0055 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.004 | |
| Type-2 angiotensin II receptor | Homo sapiens (human) | 0.0011 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kreye, VA; Schultz, G | 1 |
| George, JM; Kier, LB | 1 |
| Eley, HL; Russell, ST; Tisdale, MJ | 2 |
4 other study(ies) available for valerates and angiotensin ii
| Article | Year |
|---|---|
Inhibition of norepinephrine-, angiotensin II-, and vasopressin-induced contractions of smooth muscle by acyl derivatives of adenosine-3',5'-monophosphate.
Topics: Acylation; Adenine Nucleotides; Adenosine Monophosphate; Angiotensin II; Animals; Aorta; Butyrates; Drug Antagonism; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Norepinephrine; Rats; Valerates; Vas Deferens; Vasopressins | 1972 |
Molecular orbital studies of the conformation around the 5 position in angiotensin II.
Topics: Alanine; Aminobutyrates; Angiotensin II; Chemical Phenomena; Chemistry, Physical; Cyclohexanes; Cyclopentanes; Glycine; Isoleucine; Molecular Conformation; Norleucine; Valerates; Valine | 1974 |
Mechanism of attenuation of muscle protein degradation induced by tumor necrosis factor-alpha and angiotensin II by beta-hydroxy-beta-methylbutyrate.
Topics: Angiotensin II; Animals; Caspase 3; Caspase 8; Cells, Cultured; Down-Regulation; Drug Evaluation, Preclinical; Enzyme Inhibitors; Imidazoles; Interferon-gamma; Metabolic Networks and Pathways; Mice; Models, Biological; Muscle Fibers, Skeletal; Muscle Proteins; Muscular Atrophy; p38 Mitogen-Activated Protein Kinases; Phenylalanine; Protein Processing, Post-Translational; Pyridines; Reactive Oxygen Species; Tumor Necrosis Factor-alpha; Valerates | 2008 |
Attenuation of depression of muscle protein synthesis induced by lipopolysaccharide, tumor necrosis factor, and angiotensin II by beta-hydroxy-beta-methylbutyrate.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Carrier Proteins; Cell Cycle Proteins; Cells, Cultured; Down-Regulation; Drug Evaluation, Preclinical; eIF-2 Kinase; Eukaryotic Initiation Factor-4E; Eukaryotic Initiation Factor-4G; Eukaryotic Initiation Factors; Lipopolysaccharides; Mice; Muscle Fibers, Skeletal; Muscle Proteins; Muscular Atrophy; Phosphoproteins; Phosphorylation; Protein Biosynthesis; Tumor Necrosis Factors; Valerates | 2008 |